Orphazyme A (ORPH) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ORPH Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Orphazyme A finances operations and invests in assets.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2021)
(Dec 31 2020) 0 0 0
Assets
Cash And Cash Equivalents15.56
Current Tax Assets Current1.10
Cash & Short-term Investments16.00
Accounts receivable4.45
Other Current Assets3.07
Total Current Assets24.19
Equipment/Property/Plant Net0.45
Intangible Assets0.33
Deferred Tax Assets0.00
Other Assets, Noncurrent1.39
Total Assets26.37
Liabilities
Accounts Payable8.76
Short-term Debt5.09
Other Liabilities, Current5.80
Total Current Liabilities19.65
Total Long-term Debt0.00
Other liabilities, Noncurrent5.30
Total Liabilities24.94
Stockholders' Equity
Other Equity0.00
Common Stockholder's Equity1.42
Total Stockholder's Equity1.42
Liabilities & Stockholder's Equity26.37
4 historic quarters locked

Sign in to unlock the full Orphazyme A balance sheet history.

About Orphazyme A s Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001564590-22-024528

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.